In This Article:
Over the last 7 days, the United States market has remained flat, but it is up 33% over the past year with earnings expected to grow by 15% per annum over the next few years. In this context of strong annual growth expectations, identifying high growth tech stocks involves looking for companies that demonstrate robust innovation and adaptability in a dynamic environment.
Top 10 High Growth Tech Companies In The United States
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Super Micro Computer | 20.86% | 27.98% | ★★★★★★ |
Sarepta Therapeutics | 23.58% | 44.12% | ★★★★★★ |
TG Therapeutics | 28.39% | 43.54% | ★★★★★★ |
Invivyd | 42.91% | 70.39% | ★★★★★★ |
Ardelyx | 27.19% | 66.44% | ★★★★★★ |
Amicus Therapeutics | 20.32% | 62.37% | ★★★★★★ |
AsiaFIN Holdings | 60.53% | 81.55% | ★★★★★★ |
Travere Therapeutics | 26.51% | 69.33% | ★★★★★★ |
Seagen | 22.57% | 71.80% | ★★★★★★ |
ImmunoGen | 26.00% | 45.85% | ★★★★★★ |
Click here to see the full list of 253 stocks from our US High Growth Tech and AI Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Kanzhun
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Kanzhun Limited, with a market cap of $8.05 billion, operates as an online recruitment service provider in the People's Republic of China through its subsidiaries.
Operations: The company generates revenue primarily from its Internet Information Providers segment, amounting to CN¥6.81 billion. As an online recruitment service provider, it focuses on connecting job seekers and employers through digital platforms in China.
Kanzhun Limited, navigating through a dynamic tech landscape, has demonstrated robust financial health with a 285.6% earnings surge over the past year, outpacing the industry's growth. With an aggressive R&D investment strategy, Kanzhun is poised to maintain its technological edge, reflecting in its revenue projections for Q4 2024 which are set to increase by up to 19.5% year-on-year. The company also strategically repurchased shares worth $7.99 million recently, underscoring confidence in its operational stability and future growth prospects within the competitive Chinese market.
-
Unlock comprehensive insights into our analysis of Kanzhun stock in this health report.
-
Gain insights into Kanzhun's historical performance by reviewing our past performance report.
Concentrix
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Concentrix Corporation provides technology-infused customer experience solutions globally and has a market cap of approximately $3.33 billion.
Operations: The company generates revenue primarily from its Software & Programming segment, amounting to approximately $9.40 billion.
Concentrix, amidst a challenging fiscal landscape, reported a significant revenue jump to $2.39 billion in Q3 2024 from $1.63 billion the previous year, yet net income dipped to $16.63 million from $77.64 million, reflecting tighter profit margins now at 2.1% compared to 5.3% last year. Despite these hurdles, the company's aggressive stance on innovation is evident with R&D expenses climbing sharply; this investment is critical as it propels forward into new tech frontiers, potentially offsetting slower revenue growth projections of 3.9% annually against an industry average of 8.7%. Moreover, Concentrix has demonstrated confidence in its trajectory by repurchasing shares worth $39.1 million during the recent quarter under review. This strategic focus on research and development not only underscores Concentrix's commitment to maintaining a competitive edge but also aligns with expected earnings growth of 50.9% per annum—significantly outpacing the broader U.S market forecast of 15%. The firm’s recent guidance suggests modest optimism with projected Q4 revenues between $2.42 billion and $2.47 billion despite foreign exchange headwinds; such financial maneuvers highlight a nuanced approach to navigating market dynamics while investing heavily in future capabilities which could drive sustained long-term growth.